Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805672 · ClinicalTrials.gov registry record · Phase 4
Below Knee DVT Study
A Phase 4 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT03805672 is a Phase 4 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 4 participants.
The verdict
NCT03805672, a Phase 4 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
Hospitalized patients are at risk of developing blood clots in the legs (Deep Vein Thrombosis or DVT), which can lead to death if those clots break off and migrate to the lungs. We know that if there is a blood clot in the large leg veins near the hips and in the thighs, treating these patients with high-doses of blood thinners reduces the risk of these deaths. It is unclear if treating blood clots in the calf with high doses of blood thinners is better than using low doses. In this study, after being diagnosed with a blood clot in the calf, patients will be treated with either low dose or high dose enoxaparin (Lovenox), a blood thinner. We will then see if low dose blood thinner has similar results as high dose blood thinner.
Interventions
- DRUG Low Dose Enoxaparin
- DRUG High Dose Enoxaparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03805672
The ClinicalTrials.gov registry entry for NCT03805672 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low Dose Enoxaparin is the first listed.
NCT03805672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03805672 about?
NCT03805672 is a clinical study titled "Below Knee DVT Study". Hospitalized patients are at risk of developing blood clots in the legs (Deep Vein Thrombosis or DVT), which can lead to death if those clots break off and migrate to the lungs. We know that if there is a blood clot in the large leg veins near the hips and in the thighs, treating these patients with...
What is the current status of trial NCT03805672?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2014-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT03805672?
The interventions under investigation include: Low Dose Enoxaparin (DRUG), High Dose Enoxaparin (DRUG).
Who is sponsoring clinical trial NCT03805672?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.